NEW YORK, Dec. 6, 2014 (GLOBE NEWSWIRE) -- Veteran business journalist Kelsey Hubbard joins Jamie Macdonald, Chief Executive Officer, INC Research, Inc. [INCR] to discuss the company's industry, strategy, financials and positioning.
Click here to view video: http://www.media-server.com/m/p/q6z87jsw
Jamie Macdonald, INC Research, Inc. [INCR]
Chief Executive Officer
Jamie Macdonald serves as the Chief Executive Officer at INC Research. He has more than 16 years of senior management experience in operational and financial roles in the CRO and biopharmaceutical industries.
He joined INC Research in 2011 as COO when the Company acquired Kendle, where he also was COO. Prior to Kendle, he served as Senior Vice President and Head of Global Project Management at Quintiles. Mr. Macdonald began his career in the pharmaceutical sector as part of Syntex/Roche. He earned a Bachelor of Arts in Economics from Heriot-Watt University in Edinburgh, Scotland and is a UK qualified Chartered Management Accountant (ACMA).
Mr. Macdonald proudly serves as the current Vice Chairman of the Association of Clinical Research Organizations (ACRO).
INC Research, Inc. [INCR]
INC Research is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. We were ranked "Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries.
Source: NASDAQ CEO Signature Series;INC Research, Inc.